Follow-Up on the Use of Machine Learning in Clinical Quality Assurance: Can We Detect Adverse Event Under-Reporting in Oncology Trials?

Drug Safety - United Kingdom
doi 10.1007/s40264-019-00894-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia

JAMA Dermatology
DermatologyMedicine
2015English

Quality of Life Reporting in Multiple Sclerosis Clinical Trials: Enough Quality?

Multiple Sclerosis
Neurology
2012English

Quality Assurance of Adverse Drug Reaction Reporting and Monitoring by Clinical Pharmacists in a Tertiary Care Teaching Hospital

Indian Journal of Pharmacy Practice
2016English

Media Reporting of Practice-Changing Clinical Trials in Oncology: A North American Perspective

Oncologist
Cancer ResearchMedicineOncology
2016English

Quality Assurance, Knowledge-Based Systems, and Machine Learning

Medical Decision Making
Health Policy
1991English

Clinical Follow-Up Nursing Quality in Child Health

Health
2015English

Seasonal and Geographic Variation in Adverse Event Reporting

Drugs - Real World Outcomes
Pharmacology
2016English

Quality of Reporting in Randomized Trials

Ear, Nose and Throat Journal
MedicineOtorhinolaryngology
2010English

Physician-Reported Experience and Understanding of Adverse Event Attribution in Cancer Clinical Trials

Mayo Clinic Proceedings: Innovations, Quality & Outcomes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy